Aris Moschovitis Selected Research

Drug-Eluting Stents

12/2016	Ten-year clinical outcomes of first-generation drug-eluting stents: the Sirolimus-Eluting vs. Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) VERY LATE trial.
1/2016	Duration of Triple Antithrombotic Therapy and Outcomes Among Patients Undergoing Percutaneous Coronary Intervention.
5/2015	Clinical impact of gastrointestinal bleeding in patients undergoing percutaneous coronary interventions.
5/2014	Differential healing response attributed to culprit lesions of patients with acute coronary syndromes and stable coronary artery after implantation of drug-eluting stents: an optical coherence tomography study.
1/2013	Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stents.
8/2012	Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial.
6/2012	Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantation.
4/2012	The impact of anemia on long-term clinical outcome in patients undergoing revascularization with the unrestricted use of drug-eluting stents.
6/2011	Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents: results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aris Moschovitis Research Topics

Disease

21	Thrombosis (Thrombus) 01/2019 - 05/2010
17	Myocardial Infarction 12/2019 - 05/2010
15	Hemorrhage 10/2021 - 01/2013
14	ST Elevation Myocardial Infarction 01/2019 - 10/2011
12	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 01/2013
10	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 05/2010
9	Acute Coronary Syndrome 01/2018 - 02/2012
8	Death (Near-Death Experience) 01/2018 - 10/2011
6	Stroke (Strokes) 01/2018 - 01/2013
3	Heart Failure 12/2019 - 07/2010
3	Infarction (Infarctions) 04/2016 - 07/2010
2	Atherosclerotic Plaque (Atheroma) 01/2019 - 04/2016
2	Atrial Fibrillation 08/2015 - 01/2013
2	Anemia 01/2014 - 04/2012
1	Sepsis (Septicemia) 12/2019
1	AIDS-Related Complex (ARC) 01/2019
1	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2019
1	Dyspnea (Shortness of Breath) 01/2018
1	Inflammation (Inflammations) 01/2018
1	Chronic Renal Insufficiency 10/2017
1	Hyperplasia 10/2016
1	Peripheral Arterial Disease 10/2016
1	Cicatrix (Scar) 07/2016
1	Thrombocytopenia (Thrombopenia) 01/2016
1	Renal Insufficiency (Renal Failure) 01/2016
1	Hypertension (High Blood Pressure) 07/2015
1	Neoplasms (Cancer) 05/2015
1	Pulmonary Embolism 03/2015
1	Atherosclerosis 02/2015
1	Neointima 01/2015
1	Pathologic Constriction (Stenosis) 06/2014
1	Aortic Valve Stenosis (Aortic Stenosis) 11/2013
1	Ischemia 08/2012
1	Hypersensitivity (Allergy) 06/2012
1	Non-ST Elevated Myocardial Infarction 10/2011
1	Coronary Disease (Coronary Heart Disease) 05/2010

Drug/Important Bio-Agent (IBA)

9	omega-Chloroacetophenone (Mace)IBA 01/2019 - 05/2010
7	PolymersIBA 10/2021 - 08/2012
6	MetalsIBA 01/2019 - 05/2010
5	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 10/2021 - 10/2016
4	TicagrelorIBA 10/2020 - 01/2016
4	BESIBA 10/2020 - 06/2014
4	Clopidogrel (Plavix)FDA Link 01/2018 - 07/2015
3	Sirolimus (Rapamycin)FDA Link 10/2021 - 02/2012
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 02/2015
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 06/2015
3	Prasugrel Hydrochloride FDA Link 01/2018 - 07/2015
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2018 - 01/2013
2	ProdigyIBA 10/2017 - 10/2016
2	Everolimus FDA Link 12/2014 - 02/2012
2	Hemoglobins (Hemoglobin)IBA 01/2014 - 04/2012
2	titanium-nitride-oxideIBA 01/2012 - 05/2010
1	APTIBA 10/2021
1	AnticoagulantsIBA 10/2021
1	LipidsIBA 01/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2018
1	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2016
1	C-Reactive ProteinIBA 04/2016
1	CalciumIBA 04/2016
1	TroponinIBA 01/2016
1	Phosphates (Orthophosphate)IBA 01/2016
1	Heparin (Liquaemin)FDA LinkGeneric 01/2016
1	Trinitrotoluene (TNT)IBA 01/2016
1	Generic DrugsIBA 01/2016
1	Enoxaparin (Lovenox)FDA LinkGeneric 01/2016
1	Citric Acid (Citrate)FDA LinkGeneric 01/2016
1	Troponin T (Troponin T1)IBA 01/2016
1	Tirofiban (Aggrastat)FDA Link 01/2016
1	bivalirudin (Angiomax)FDA Link 01/2016
1	Rosuvastatin Calcium (Crestor)FDA Link 02/2015
1	Phenobarbital (Luminal)FDA Link 01/2015
1	CreatinineIBA 01/2014
1	Vitamin K FDA Link 01/2013
1	Stainless Steel (Steel, Stainless)IBA 05/2010

Therapy/Procedure

29	Stents 10/2021 - 05/2010
19	Percutaneous Coronary Intervention 12/2019 - 07/2010
14	Therapeutics 10/2021 - 07/2010
9	Drug-Eluting Stents 12/2016 - 06/2011
3	Patient Readmission 12/2019 - 07/2010
1	Duration of Therapy 01/2019
1	Septal Occluder Device 08/2015
1	Cardiopulmonary Resuscitation (CPR) 03/2015
1	Catheters 03/2015
1	Transcatheter Aortic Valve Replacement 11/2013
1	Cell- and Tissue-Based Therapy (Cell Therapy) 07/2010